ProCE Banner Activity

Considerations for Treatment of Ulcerative Colitis: The Role of Ozanimod

Clinical Thought

A gastroenterology expert discusses S1P receptor modulators and how they fit into optimizing the care for patients with ulcerative colitis.

Released: March 16, 2023

Expiration: March 14, 2024



Jordan Axelrad

Jordan Axelrad, MD, MPH

Associate Professor
NYU Grossman School of Medicine
Clinical and Translational Research
Inflammatory Bowel Disease Center at NYU Langone Health
New York, New York

Provided by

ProCE Banner


This activity is supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Jordan Axelrad, MD, MPH: consultant/advisor/speaker: AbbVie, Adiso, Bristol-Myers Squibb, Fresenius, Janssen, Pfizer.